- Novadaq Technologies Inc. NVDQ shares surged 95 percent to $11.70 after the company agreed to be purchased by Stryker Corporation SYK for $11.75 per share in cash.
- Clovis Oncology Inc CLVS shares climbed 43.7 percent to $86.17 after the company released encouraging late-stage data from an ongoing trial called ARIEL3. Top-line data from the phase 3 ARIEL3 trial successfully achieved its primary endpoint of improved progression-free survival in each of the three populations studied, Clovis stated. Moreover, PFS was also improved among the rucaparib group compared with placebo by blinded independent central review, a key secondary endpoint. Chardan Capital upgraded Clovis Oncology from Sell to Neutral.
- Rice Energy Inc RICE shares jumped 25.4 percent to $24.58 as EQT Corporation EQT announced plans to buy the company for $6.7 billion.
- Adomani Inc ADOM shares gained 13.3 percent to $10.88.
- Rigel Pharmaceuticals, Inc. RIGL surged 10.4 percent to $2.76 after the company disclosed that its New Drug Application for TAVALISSE is accepted by the FDA.
- Bellicum Pharmaceuticals Inc BLCM shares climbed 9.4 percent to $12.40.
- CAI International Inc CAI shares surged 9.1 percent to $22.89 after the company reported an expansion of its revolving credit facility. CAI also expects Q2 earnings of $0.55 to $0.58 per share.
- Cobalt International Energy, Inc. CIE shares rose 8.6 percent to $3.39.
- Exelixis, Inc. EXEL shares gained 8 percent to $20.79. IRC has confirmed that cabozantinib has significantly improved progression-free survival compared to sunitinib.
- Key Energy Services, Inc. KEG shares climbed 7.9 percent to $16.85.
- JD.Com Inc(ADR) JD shares rose 5 percent to $40.07. JD.Com reported that transaction volume of "6.18" anniversary sales event rose over 50 percent in the first 18 days versus first 18 days in 2016.
- Valeant Pharmaceuticals Intl Inc VRX gained 4.8 percent to $13.26 after the company reported that John Paulson joined its board of directors.
- United States Steel Corporation X rose 4.1 percent to $20.97. Longbow Research upgraded United States Steel from Neutral to Buy.
- AK Steel Holding Corporation AKS shares surged 4 percent to $6.23. Longbow Research upgraded AK Steel from Neutral to Buy.
- Nucor Corporation NUE gained 3.4 percent to $56.75. Longbow Research upgraded Nucor from Neutral to Buy.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: NewsIntraday UpdateMarketsAnalyst RatingsMoversInformation TechnologyIT Consulting & Other ServicesTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
